Target
Induced myeloid leukemia cell differentiation protein Mcl-1
Ligand
BDBM333146
Substrate
n/a
Meas. Tech.
Biochemical binding TR-FRET assay
IC50
<3.00±n/a nM
Citation
 Hird, ABelmonte, MYang, WSecrist, PRobbins, DKazmirski, SWu, DPeng, BJohannes, JLamb, MYe, QZheng, X MCL-1 inhibitors and methods of use thereof US Patent  US10196404 Publication Date 2/5/2019 
Target
Name:
Induced myeloid leukemia cell differentiation protein Mcl-1
Synonyms:
BCL2L3 | Bcl-2-like protein 3 | Bcl-2-like protein 3 (Mcl-1) | Bcl-2-related protein EAT/mcl1 | Bcl2-L-3 | Induced myeloid leukemia cell differentiation protein (Mcl-1) | MCL1 | MCL1_HUMAN | Mcl-1 | Myeloid Cell factor-1 (Mcl-1) | Myeloid cell leukemia sequence 1 (BCL2-related) | mcl1/EAT
Type:
Membrane; Single-pass membrane protein
Mol. Mass.:
37332.87
Organism:
Homo sapiens (Human)
Description:
Q07820
Residue:
350
Sequence:
MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR
  
Inhibitor
Name:
BDBM333146
Synonyms:
Compound I | US10196404, Example 1 | US10196404, Example 2 | US10196404, Example 3 | US11472816, Example 3 | US11691989, Compound AZD5991
Type:
Small organic molecule
Emp. Form.:
C35H34ClN5O3S2
Mol. Mass.:
672.259
SMILES:
Cc1c-2c(CSCc3cc(CSc4cc(OCCCc5c(C(O)=O)n(C)c6c-2c(Cl)ccc56)c2ccccc2c4)n(C)n3)nn1C
Structure:
Search PDB for entries with ligand similarity: